Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Kobo-Angel - Outspreaded Angel Wings Pin
Popular Articles

The Spelling Mistake In The Genetic Code That Causes A Type Of Ovarian Cancer
Eureka! Vancouver scientists from the Ovarian Cancer Research (OvCaRe) Program at BC Cancer Agency and Vancouver Coastal Health Research Institute have discovered that there appears to be a single spelling mistake in the genetic code of granulosa cell tumours, a rare and often untreatable form of ovarian cancer. This means that out of the three billion nucleotide pairs that make up the genetic code of the tumour, one - the same one in every tumour sample - is incorrect. The discovery, published online June 10th in the New England Journal of Medicine, marks the beginning of a new era of cancer genomics, where the complete genetic sequence of cancers can be unravelled and the mutations that cause them exposed. For women with granulosa cell tumours it represents the first specific diagnostic tool and clear path to develop much needed treatments for this cancer.

Northeast Colorado Conference Discusses HIV/AIDS Needs Assessment Findings
Rural Solutions, an organization in northeast Colorado, held the "Community HIV/AIDS Education and Action Conference" as part of its ongoing effort to address issues related to HIV, the Sterling Journal-Advocate reports. At the conference, the organization presented the results of a recent needs assessment of HIV/AIDS services in the northeastern part of the state - conducted in partnership with the Center for Research Strategies and funded through the Colorado Department of Public Health and Environment - which found that HIV prevention services in the area are limited; barriers exist for HIV testing including confidentiality and costs; and mental health and substance use services for at-risk people also are limited, according to the Journal-Advocate (Jones, Sterling Journal-Advocate, 6/17).
News of the day
U.S. Has Pent-Up Demand For Eldercare Capable Personal Robots
GeckoSystems Intl. Corp. (PINKSHEETS: GCKO) announced that they expect pent-up demand for their cost effective, home based eldercare personal robots. This new type of modern eldercare will postpone, if not eliminate, many elderly persons from having to endure the loneliness and loss of independence when living in nursing homes, and other assisted living facilities. Their families can now better manage the difficult decisions regarding independence they allow their now dependent aged parent while minimizing the concern and risk the adult caregiving child is willing to assume to enable an acceptable level of independence for their now dependent parent. GeckoSystems is a dynamic leader in the emerging Mobile Service Robot industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service™."
Mental Health

Proceedings Of NIAID Workshop On Immunity To Malaria Published

Researchers have made progress in developing malaria vaccines over the past few decades, but the goal remains a daunting challenge. Malaria has evolved to thwart almost every aspect of the human immune system. On March 16-17, 2009, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, convened a workshop to encourage more immunologists to enter malaria research and to foster scientific collaborations that may help lead to the development of effective malaria vaccines. The proceedings of that meeting are in the July 2009 issue of Nature Immunology, and available online June 18. Nearly half of the world"s population, or about 3.3 billion people, are at risk of malarial infection, and it causes more than 250 million clinical episodes and one million deaths each year. Anyone can get malaria but pregnant women, young children, and first-time suffers often have more complicated infections. Unlike diseases such as chickenpox and measles, where a single infection offers life-long immunity, bouts of malaria can occur repeatedly. Individuals acquire malaria through the bite of Anopheles mosquitoes infected with any of four species of Plasmodium parasites. To develop a protective malaria vaccine, researchers must identify which of the Plasmodium parasite"s 5,300 proteins provoke a strong immune response. Further complicating vaccine development, the parasite makes different proteins at each stage of its lifecycle. NIAID recognizes that collaboration among scientists of diverse disciplines is necessary to accelerate research in malaria. The goals of the NIAID-supported workshop were to identify research gaps in malaria immunology; address issues that hinder immunologists from conducting malaria research; identify res to facilitate studies of immunity in malaria; and challenge immunologists to join with their colleagues in unraveling the immune mechanisms that protect against or contribute to the development and effects of malarial disease. NIAID is the lead U.S. government agency that supports basic biomedical and clinical research in malaria. The NIAID Malaria Research Agenda and Strategic Plan, both published in April 2008, emphasize the need for improved understanding of host immune responses to malaria parasite infection and the relationship between immune responses and disease pathogenesis. ARTICLE: AD Augustine, et al. NIAID Workshop on Immunity to Malaria: Addressing Immunological Challenges. Nature Immunology DOI:10.1038/ni0709-673 (2009). WHO: Anthony S. Fauci, M.D., Director of NIAID; or Alison Deckhut Augustine, Ph.D., Chief, Immunoregulation Section, Basic Immunology Branch, NIAID Linda Perrett NIH/National Institute of Allergy and Infectious Diseases


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009